Comparative bioavailability of two tablet preparations of metronidazole
- PMID: 3182111
Comparative bioavailability of two tablet preparations of metronidazole
Abstract
In a randomized cross-over study, eight healthy volunteers received single 200 mg doses of metronidazole tablets (as either the May and Baker or Servipharm preparation) after an overnight fast. The bioavailability of these two preparations did not differ significantly as judged from the peak plasma concentration, time to peak plasma concentration and area under the plasma concentration-time curve. Metronidazole was found to have a plasma clearance of 1.05 +/- 0.14 (s.d.) and 0.98 +/- 0.17 ml min-1 kg-1, a plasma terminal half-life of elimination of 9.15 +/- 1.01 and 10.35 +/- 1.59 h, and an apparent volume of distribution of 0.83 +/- 0.06 l kg-1 (the values obtained with the May and Baker preparation being shown before the Servipharm preparation in each case).
Similar articles
-
Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.Int J Clin Pharmacol Res. 1987;7(4):239-42. Int J Clin Pharmacol Res. 1987. PMID: 3596865 Clinical Trial.
-
Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.Scand J Gastroenterol Suppl. 1984;91:45-60. Scand J Gastroenterol Suppl. 1984. PMID: 6588489
-
The bioavailability of commercial metronidazole formulations.Int J Clin Pharmacol Biopharm. 1978 Mar;16(3):110-5. Int J Clin Pharmacol Biopharm. 1978. PMID: 649227
-
Bioavailability of metronidazole formulations (Vagimid).Pharmazie. 1992 Jul;47(7):522-5. Pharmazie. 1992. PMID: 1518897
-
Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.Int J Clin Pharmacol Ther. 1997 Jun;35(6):255-60. Int J Clin Pharmacol Ther. 1997. PMID: 9208342 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous